Compare

Axon/$AXON

1D1W1M3M6MYTD1Y5YMAX

About Axon

Axon was founded in 1993, but its roots trace back to the invention of the Taser in 1974 by Jack Cover. Over the decades, Axon has expanded its product suite to include police body-worn cameras, a cloud-based evidence repository, AI-driven report-drafting software, drones and counter-drone sensors, and 911 dispatching software. The firm sells its products to end markets such as local and federal law enforcement, enterprise, corrections, and healthcare. It derives around four-fifths of its revenue from the US, with the remainder from international countries.
Ticker
$AXON
Primary listing
NASDAQ
Employees
5,100

Axon Metrics

BasicAdvanced
$34B
174.83
$2.40
1.40
-

What the Analysts think about Axon

Analyst ratings (Buy, Hold, Sell) for Axon stock.
Analyst projections of the future price of Axon stock.

Bulls say / Bears say

Axon raised its 2026 revenue growth outlook to 32%–34% after Q2 revenue rose 35%, and future contracted bookings grew 41% to $15.1 billion. That gives the company strong near-term growth momentum and a sizeable pipeline to convert into sales. (Axon)
Recurring software revenue is growing quickly: annual recurring revenue rose 39% to $1.6 billion and net revenue retention reached 126%. Newer software offerings grew about 70%, suggesting customers are adopting more tools across Axon’s platform. (Axon)
Axon is extending beyond its established US police market: international and enterprise bookings each roughly tripled year on year in Q2, while counter-drone products and Axon 911 are widening its offer. Success in these newer markets could diversify its growth over time. (Axon)
Q2 gross margin fell, as a greater mix of lower-margin professional services and investment in scaling new products weighed on results. If those costs persist, rapid sales growth may not translate into comparable profit growth. (Reuters)
Axon’s $15.1 billion future-bookings figure is not the same as contracted revenue recognised under accounting rules: its Q2 filing reported $9.8 billion of remaining performance obligations. The filing says delivery can be delayed or affected by budget approvals and cancellation clauses, creating uncertainty over the timing and realisation of the wider bookings pipeline. (Axon, SEC)
Axon’s push into AI and surveillance technology faces growing public scrutiny, including criticism that its report-writing AI can make errors. Los Angeles also delayed a planned pilot of its AI-enabled licence-plate readers, illustrating how privacy concerns could slow deployments or damage trust. (Fortune)
Data summarised monthly by Lightyear AI. Last updated on 14 Oct 2026.

Axon Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Axon Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.